Investigation into Potential Fiduciary Duties Breaches at Atkore, Axsome Therapeutics, Capricor Therapeutics, and CTO Realty Growth
ByAinvest
Thursday, Mar 12, 2026 10:40 am ET1min read
ATKR--
AXSM--
CAPR--
CTO--
Johnson Fistel, PLLP is investigating claims against Atkore Inc., Axsome Therapeutics, Capricor Therapeutics, and CTO Realty Growth on behalf of long-term shareholders. Shareholders who held shares continuously since prior to specified dates may have standing to seek corporate governance reforms, the return of funds, and a court-approved incentive award. The investigations relate to alleged anticompetitive practices, CMC issues, and misleading statements.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet